What is edaravone for?
Edaravone is a medicine for treating acute and ischemic stroke. It also helps patients with ALS.
How does edaravone work?
Free radicals like hydroxyl radical are key in stroke. They damage cells and cause brain problems.
When blood flow drops, free radicals increase. This causes cell damage and brain issues. Edaravone fights these free radicals. It protects cell membranes.
Where has edaravone been approved?
Edaravone is approved in Japan for treating acute cerebral infarction.
In Japan, it’s called Radicut, and in the USA, Radicava. Mitsubishi Tanabe makes them. They are approved for ALS treatment. Daiichi Sankyo also makes a generic version. For more information, contact our support team.
Always talk to a doctor before choosing a generic or brand medicine. The FDA has warned about quality issues with some medicines from India.
How is edaravone taken?
For treating cerebral infarction, see our resources section for details.
- Edaravone is given as 30 mg intravenously over 30 minutes twice a day.
- Start within 24 hours of stroke onset. Use for 14 days.
- Stop sooner if symptoms improve.
Edaravone is also in Radicut and Radicava for ALS. Adults with ALS get:
- 60 mg intravenously over 60 minutes once a day.
- First cycle: 14 days of treatment, then 14 days off.
- After that, 10 days of treatment, then 14 days off.
Edaravone comes in two forms:
- Single-dose infusion bags with 30 mg / 100 mL solution. Ready to use.
- Single-dose vials with 30 mg / 20 mL solution. Dilute with saline before use.
Reviews
There are no reviews yet.